AUSTIN SUE: Open Payments
NPI 1487916045 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113 in 4 payments from 4 companies in 2025. Trend: 2023 $42 · 2024 $57 · 2025 $113
Food & beverage: $113
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: LYNOZYFIC, LIBTAYO, Belbuca, ICLUSIG.
Industry payments across CA — which companies pay providers there.
